Health Biz Cheat Sheet: Merck and Medtronic Make Headlines
Merck & Co. (NYSE:MRK) reported its third quarter net income rose to $1.69 billion (55 cents per share) vs. $341.6 million (11 cents per share) in the same quarter a year earlier. This represents...
View ArticleHealthcare Stock Recap: St. Jude Medical Hit by FDA, JNJ Collaborates with...
GSK’s (NYSE:GSK) Tykerb fails to hit its goal in a Phase III trial. The trial tested Tykerb use in women with early stage breast cancer. Tykerb, a rival to Roche’s (RHHBY.PK) Herceptin, is approved in...
View ArticleWhat’s Moving These Stocks: Allos Therapeutics, Seagate Technology, Polycom,...
Allos Therapeutics, Inc. (NASDAQ:ALTH) and Spectrum Pharmaceuticals (NASDAQ:SPPI) ink an agreement allowing Spectrum to acquire all of Allos’outstanding shares at $1.82 in cash, plus one Contingent...
View ArticleHealthcare Business Review: Teva’s Lawsuits, Allos Therapeutics Rockets
In a deal worth approximately $300 million in cash, Israel-based Oridion Systems (ORDNF.PK) is acquired by Covidien (NYSE:COV), who characterizes Oridion’s products as “excellent complements to the...
View ArticleHealthcare Business Recap: Bristol-Myers’ Subpoena, Varian Medical Earnings
Medical equipment and software producer Varian Medical (NYSE:VAR) shares were unaffected by its fairly upbeat fiscal second quarter report, and down on the lower annual guidance of between $3.76 and...
View ArticleKraft Hits a SELECT LIST and 4 Stocks with New Analyst Insights Now
Kraft Foods Inc. (NYSE:KFT): Ahead of the company’s split-up, Stifel Nicolaus added Kraft to its Select List. The company believes that the stock’s risk/ratio is favorable, it maintains a $44 target on...
View ArticleHealthcare Biz Report: OraSure’s Home HIV TEST, Roche’s Lucentis OKAYED
A new home test for HIV is given credit for OraSure Technologies, Inc.(NASDAQ:OSUR) getting initial coverage by Jefferies with a Buy, and a price target of $14. The research company points to the...
View ArticleHealthcare Business Report: MAKO’s PROFITABLE Link, Spectrum Will BUY Allos
Shares of MAKO Surgical Corp. (NASDAQ:MAKO) popped on word of an impressive sales report from its British supplier Corin Group Plc (CNGHF.PK). For its part, Corin says that its first half sales jumped...
View ArticleDoes Spectrum Pharmaceuticals Have The Prescription These Top Institutional...
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) claims that the integration of Allos Therapeutics has surpassed expectations. Anticipated synergies are predicted to be at $50 million or higher, which...
View ArticleClik here to view.
4 Merger and Acquisitions Stock Stories Making Midweek Headlines
Yahoo! Inc. (NASDAQ:YHOO): Current price $29.66 On Wednesday, Yahoo! announced the purchase of the advanced mobile ad tech startup Admovate. The firm has created sophisticated technology that helps...
View Article
